M. Cianfrocca
The Oncologist · 2004
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom M. Cianfrocca trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from M. Cianfrocca's perspective
Ordered by how strongly the researchers M. Cianfrocca trusts endorse each paper. Same corpus, a different order for every researcher.
- A gene-expression signature as a predictor of survival in breast cancer. (New England Journal of Medicine)
- Lymphatic mapping and sentinel lymphadenectomy for breast cancer. (American Journal of Surgery)
- The RAF proteins take centre stage (Nature reviews. Molecular cell biology)
- Immune Checkpoint Targeting in Cancer Therapy: Towards Combination Strategies with Curative Potential (Cell)
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation (Nature)
- Immunogenicity of somatic mutations in human gastrointestinal cancers (Science)
- The InterPro protein families database: the classification resource after 15 years
- PD-1 blockade induces responses by inhibiting adaptive immune resistance (Nature)
- VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. (Genome Research)
- GSVA: gene set variation analysis for microarray and RNA-Seq data (BMC Bioinformatics)
Their papers
- Prognostic and predictive factors in early-stage breast cancer. (2004) — 671 citations